Prehabilitation for people with prostate cancer
Prehabilitation to Patients With Prostate Cancer, Who Are About to Receive Androgen Deprivation Therapy and Radiation Therapy
NA · Odense University Hospital · NCT07162987
This project will test a 12-week multicomponent prehabilitation program, including a 4-day residential course and supervised exercise, to see if it helps men with prostate cancer starting androgen deprivation plus radiation therapy better tolerate treatment side-effects.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 20 (estimated) |
| Ages | 18 Years and up |
| Sex | Male |
| Sponsor | Odense University Hospital (other) |
| Locations | 3 sites (Esbjerg, Region Syddanmark and 2 other locations) |
| Trial ID | NCT07162987 on ClinicalTrials.gov |
What this trial studies
This is a feasibility study of a newly developed multicomponent prehabilitation program for patients with prostate cancer who will receive androgen deprivation therapy and radiation. Participants take part in 12 weeks of physical exercise training and attend a 4-day residential prehabilitation course that includes education and practical exercises, with an optional follow-up session. The study will collect questionnaires from patients and close relatives and gather feedback from healthcare professionals to determine acceptability and feasibility. The investigators will also look for indications of clinical effect and whether the planned data collection methods work in this setting.
Who should consider this trial
Good fit: Ideal candidates are adults diagnosed with prostate cancer who are scheduled for androgen deprivation therapy plus radiation, live in Vejle or Esbjerg Municipality, can attend the residential prehabilitation in week 43 or 50 of 2025, speak and read Danish, and can participate in group-based exercise and education sessions.
Not a fit: Patients who cannot travel to the residential stay, cannot participate in group sessions, do not speak Danish, have limiting comorbidities that prevent exercise, or are not receiving the specified ADT plus radiation treatment are unlikely to benefit from this program.
Why it matters
Potential benefit: If successful, the program could help patients better withstand treatment side-effects and maintain quality of life during and after therapy.
How similar studies have performed: Prehabilitation interventions have shown promise in improving resilience and recovery in other cancer and surgical populations, but multicomponent residential prehabilitation specifically for prostate cancer patients receiving ADT and radiation remains relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosed with prostate cancer * min 18 years old * Treatment: Androgen deprivation therapy and raditation therapy * Resident in Vejle Municipality or Esbjerg Municipality * Can take part in residential prehabiliation in week 43 or 50, 2025, as well as physical exsercise training in the municipality * Willing to take part in a research study * Suited to take part in group sessions * Be able to read and be understood in Danish * Be responsible for own personal hygiene and medications at the 4-day residential stay Exclusion Criteria: * Persons who do not fulfil the inclusion criteria will be excluded
Where this trial is running
Esbjerg, Region Syddanmark and 2 other locations
- Esbjerg Hospital — Esbjerg, Region Syddanmark, Denmark (RECRUITING)
- REHPA, the Danish Knowledge Centre for Rehabilitation and Palliative Care — Nyborg, Region Syddanmark, Denmark (RECRUITING)
- Vejle Hospital — Vejle, Region Syddanmark, Denmark (RECRUITING)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Prostate Cancer, prostate cancer, prehabilitation, androgen deprivation therapy, radiation therapy